F5 Inc. Stock Rallies 3.9%, Outperforms Market
Dow Jones2026/10/09 20:35This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of F5 Inc. advanced 3.9% to $479.83 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.6% to 7,811.54 and the Dow Jones Industrial Average rising 0.8% to 51,654.95. The stock's rise snapped a two-day losing streak. F5 Inc. hit a new 52-week high, surpassing its previous peak of $472.25, which the company reached on October 7th. The stock outperformed some of its peers, as Globant S.A. fell 2.0% to $36.32. Trading volume totaled 500,841, compared to the 50-day average of 554,527. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 09, 2026 16:35 ET (20:35 GMT)
This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of F5 Inc. advanced 3.9% to $479.83 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.6% to 7,811.54 and the Dow Jones Industrial Average rising 0.8% to 51,654.95.
The stock's rise snapped a two-day losing streak.
F5 Inc. hit a new 52-week high, surpassing its previous peak of $472.25, which the company reached on October 7th.
The stock outperformed some of its peers, as Globant S.A. fell 2.0% to $36.32.
Trading volume totaled 500,841, compared to the 50-day average of 554,527.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 09, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: 10.10 Bitcoin/Ethereum Evening Trading Strategies and Market Analysis
Tekedia Capital flags signs global bond sell-off is losing momentum
Dogecoin ETF to Shut as Bitwise CEO Flags Weak Demand
TD Cowen lowers UnitedHealth target price to $402